Connect with us on Facebook
Follow us on Twitter
DOWNLOAD
SITE SEARCH
EMAIL UPDATES
Want to keep on top of what's going on in our community? It's easy! SIGN UP TODAY for the Dallas Voice's weekly Email update and have the latest news and information sent directly to you.
EMAIL ADDRESS
EMAIL ADDRESS
Last Updated: May 22, 2009 - 10:25:28 AM
FDA approves new HIV test
By Associated Press
Jan 7, 2009 - 9:27:26 AM
New test screens for 2 less common forms of virus
WASHINGTON — Federal regulators said Dec. 30 they have approved a new HIV test that screens for two, less common forms of the virus.
The Food and Drug Administration said the TaqScreen MPX Test is the first to simultaneously detect HIV-2 and HIV-1 Group O strains. Both types of HIV are mainly found among patients in Africa, but the FDA said they have recently been detected in the U.S.
The test, which is made by a division of Swiss drugmaker Roche, also screens for the most common forms of HIV and hepatitis.
The MPX test is designed to screen for infectious diseases in human blood and tissue samples from donors.
“Blood donor testing laboratories will be able to use nucleic acid technology to screen for additional HIV strains, further assuring that donated blood and tissue are free from infection,” FDA division chief Jesse Goodman said in a statement.
Other companies offering HIV tests include Abbott Laboratories and Gen-Probe Inc.
Roche Molecular Systems Inc. is based in Pleasanton, California.
WASHINGTON — Federal regulators said Dec. 30 they have approved a new HIV test that screens for two, less common forms of the virus.
The Food and Drug Administration said the TaqScreen MPX Test is the first to simultaneously detect HIV-2 and HIV-1 Group O strains. Both types of HIV are mainly found among patients in Africa, but the FDA said they have recently been detected in the U.S.
The test, which is made by a division of Swiss drugmaker Roche, also screens for the most common forms of HIV and hepatitis.
The MPX test is designed to screen for infectious diseases in human blood and tissue samples from donors.
“Blood donor testing laboratories will be able to use nucleic acid technology to screen for additional HIV strains, further assuring that donated blood and tissue are free from infection,” FDA division chief Jesse Goodman said in a statement.
Other companies offering HIV tests include Abbott Laboratories and Gen-Probe Inc.
Roche Molecular Systems Inc. is based in Pleasanton, California.
© Copyright by DallasVoice.com
Top of Page
The following comments were posted by readers and were not edited by Dallas Voice. When you comment, stay on topic and treat others with respect. Posts deemed offensive will be removed.
No comments yet
Post a Comment:
